Skip to content
value.today

Cardialen, Inc.

🇺🇸 St. Louis, Missouri, USAHealth CareFounded 2008
Total raised
$27 M
5 rounds on record
Latest round
$4 M
Jun 2021
First round on record
Sep 2010
Today
Private
No later event on record

Funding rounds

5 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Cardialen, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2021$4 MNo. 5$2 to $10 million

Cardialen, Inc.: Raise no. 5, Jun 2021

Investors in this round

18 investors had bought by the notice of Jul 9, 2021: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered
Smallest investment taken
$967
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff Peters · Executive Officer, Director
  • Anna French · Director
  • Jay Schmelter · Director
  • Thomas Thaler · Director
  • Warren Watson · Director
  • William Schmidt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeff Peters, Ceo. Source: SEC Form D, newest notice filed Jul 9, 2021. Read the notice at the SEC.

debt, optionsSEC
Jul 2018$16 MNo. 4$10 to $50 million

Cardialen, Inc.: Raise no. 4, Jul 2018

Investors in this round

16 investors had bought by the notice of Aug 8, 2018: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$16 M of $16 M offered
Smallest investment taken
$8,241
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeff Peters · Executive Officer, Director
  • Brian Beutner · Director
  • Eric Gulve · Director
  • Igor Efimov · Director
  • Robert Calcaterra · Director
  • Warren Watson · Director
  • William Schmidt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes compensation (salary and bonus) for officers.”

Signed by Jeff Peters, Chief Executive Officer. Source: SEC Form D, newest notice filed Aug 8, 2018. Read the notice at the SEC.

equitySEC
Mar 2015$2 MNo. 3Under $2 million

Cardialen, Inc.: Raise no. 3, Mar 2015

Investors in this round

22 investors had bought by the notice of Jun 10, 2015: 22 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered; $0 M still to sell
Smallest investment taken
$10,000
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eric A. Gulve · Executive Officer, Director
  • M. Brent Shelton · Executive Officer
  • Paula J. Skjefte · Executive Officer, Director
  • Brian Buetner · Director
  • Igor J. Efimov · Director
  • Robert J. Calcaterra · Director
  • Warren A. Watson · Director
  • William Brent Schmidt · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paul Skjefte, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 10, 2015. Read the notice at the SEC.

equitySEC
Dec 2013$3 MNo. 2$2 to $10 million

Cardialen, Inc.: Raise no. 2, Dec 2013

Investors in this round

18 investors had bought by the notice of Jan 13, 2014: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$3 M of $4 M offered; $1 M still to sell
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Eric A. Gulve · Executive Officer, Director
  • M. Brent Shelton · Executive Officer
  • Nick Brent Lanners · Executive Officer
  • Paula R. Skjefte · Executive Officer, Director
  • Brian Buetner · Director
  • Igor R. Efimov · Director
  • Robert J. Calcaterra · Director
  • Warren A. Watson · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Paula Skjefte, Chief Executive Officer. Source: SEC Form D, newest notice filed Jan 13, 2014. Read the notice at the SEC.

equitySEC
Sep 2010$2 MNo. 1$2 to $10 million

Cardialen, Inc.: Raise no. 1, Sep 2010

Investors in this round

7 investors had bought by the notice of Dec 16, 2011: 6 accredited, 1 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M (amount offered: indefinite)
Smallest investment taken
$15,000
What was sold
debt, options or other rights to buy securities
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Robert J. Calcaterra · Executive Officer, Director
  • Eric A. Gulve · Director
  • Igor R. Efimov · Director
  • Paula A. Skjefte · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Robert J. Calcaterra, President & CEO. Source: SEC Form D, newest notice filed Dec 16, 2011. Read the notice at the SEC.

debt, optionsSEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Cardialen, Inc. chose not to state its revenue in its newest notice of a funding round (Jul 2021).

    SEC Form D · Jul 2021

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2021

That is all the official record says: Cardialen, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Cardialen, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 22 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Cardialen, Inc.
NameRoleNamed in
Jeff PetersExecutive officerJul 2021
Eric A. GulveExecutive officerJun 2015
M. Brent SheltonExecutive officerJun 2015
Paula J. SkjefteExecutive officerJun 2015
Nick Brent LannersExecutive officerJan 2014
Paula R. SkjefteExecutive officerJan 2014
Robert J. CalcaterraExecutive officerDec 2011
Anna FrenchDirectorJul 2021
Jay SchmelterDirectorJul 2021
Jeff PetersDirectorJul 2021
Thomas ThalerDirectorJul 2021
Warren WatsonDirectorJul 2021
William SchmidtDirectorJul 2021
Brian BeutnerDirectorAug 2018
Eric GulveDirectorAug 2018
Igor EfimovDirectorAug 2018
Robert CalcaterraDirectorAug 2018
Brian BuetnerDirectorJun 2015
Eric A. GulveDirectorJun 2015
Igor J. EfimovDirectorJun 2015
Paula J. SkjefteDirectorJun 2015
Robert J. CalcaterraDirectorJun 2015
Warren A. WatsonDirectorJun 2015
William Brent SchmidtDirectorJun 2015
Igor R. EfimovDirectorJan 2014
Paula R. SkjefteDirectorJan 2014
Paula A. SkjefteDirectorDec 2011